MX2023008024A - Dispositivo y farmaco antitumoral para el tratamiento de celulas neoplasicas. - Google Patents
Dispositivo y farmaco antitumoral para el tratamiento de celulas neoplasicas.Info
- Publication number
- MX2023008024A MX2023008024A MX2023008024A MX2023008024A MX2023008024A MX 2023008024 A MX2023008024 A MX 2023008024A MX 2023008024 A MX2023008024 A MX 2023008024A MX 2023008024 A MX2023008024 A MX 2023008024A MX 2023008024 A MX2023008024 A MX 2023008024A
- Authority
- MX
- Mexico
- Prior art keywords
- neoplastic cells
- antitumor drug
- treatment
- electric current
- target region
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 4
- 229940041181 antineoplastic drug Drugs 0.000 title abstract 4
- 210000005170 neoplastic cell Anatomy 0.000 title abstract 4
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36002—Cancer treatment, e.g. tumour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Electrotherapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un fármaco antitumoral para su uso en un método para bloquear o inhibir el crecimiento de células neoplásicas en una región objetivo de un organismo vivo. El método comprende tratar las células neoplásicas con dicho fármaco antitumoral simultáneamente con la aplicación de ondas de corriente eléctrica a la región objetivo durante un periodo de tiempo predefinido mientras las células neoplásicas son tratadas con el fármaco antitumoral, teniendo las ondas de corriente eléctrica una forma de onda con una frecuencia fundamental mayor o igual a 2 MHz.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000000119A IT202100000119A1 (it) | 2021-01-05 | 2021-01-05 | Dispositivo e farmaco antitumorale per il trattamento di cellule neoplastiche |
| PCT/IB2022/050042 WO2022149061A1 (en) | 2021-01-05 | 2022-01-04 | Device and antitumor drug for the treatment of neoplastic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023008024A true MX2023008024A (es) | 2023-07-14 |
Family
ID=74875229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023008024A MX2023008024A (es) | 2021-01-05 | 2022-01-04 | Dispositivo y farmaco antitumoral para el tratamiento de celulas neoplasicas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240066008A1 (es) |
| EP (1) | EP4274550A1 (es) |
| JP (1) | JP2024515405A (es) |
| KR (1) | KR20230118603A (es) |
| CN (1) | CN116782945A (es) |
| AU (1) | AU2022205800A1 (es) |
| CA (1) | CA3206892A1 (es) |
| IL (1) | IL303872A (es) |
| IT (1) | IT202100000119A1 (es) |
| MX (1) | MX2023008024A (es) |
| WO (1) | WO2022149061A1 (es) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1087691B1 (en) | 1998-06-18 | 2002-05-08 | Telea Electronic Engineering S.R.L. | Radiofrequency electrosurgical generator with current control |
| US8019414B2 (en) * | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
| US20170209579A1 (en) * | 2014-07-24 | 2017-07-27 | Baylor College Of Medicine | Non-invasive radiofrequency field treatment for cancer therapy |
| US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
| US20200368525A1 (en) * | 2017-11-17 | 2020-11-26 | Abbvie Inc. | Methods of Treating Glioblastoma |
| JP7055906B2 (ja) * | 2018-07-03 | 2022-04-18 | エドウィン・チャン | 細胞膜透過性を増加させるための交流電界の使用 |
| WO2020170164A1 (en) | 2019-02-22 | 2020-08-27 | Moshe Giladi | Treating gastric cancer using ttfields combined with xelox or folfox |
-
2021
- 2021-01-05 IT IT102021000000119A patent/IT202100000119A1/it unknown
-
2022
- 2022-01-04 MX MX2023008024A patent/MX2023008024A/es unknown
- 2022-01-04 US US18/259,326 patent/US20240066008A1/en active Pending
- 2022-01-04 IL IL303872A patent/IL303872A/en unknown
- 2022-01-04 EP EP22701700.1A patent/EP4274550A1/en active Pending
- 2022-01-04 WO PCT/IB2022/050042 patent/WO2022149061A1/en active Application Filing
- 2022-01-04 CA CA3206892A patent/CA3206892A1/en active Pending
- 2022-01-04 KR KR1020237022667A patent/KR20230118603A/ko unknown
- 2022-01-04 JP JP2023539308A patent/JP2024515405A/ja active Pending
- 2022-01-04 AU AU2022205800A patent/AU2022205800A1/en active Pending
- 2022-01-04 CN CN202280009073.XA patent/CN116782945A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL303872A (en) | 2023-08-01 |
| CN116782945A (zh) | 2023-09-19 |
| WO2022149061A1 (en) | 2022-07-14 |
| AU2022205800A1 (en) | 2023-07-13 |
| KR20230118603A (ko) | 2023-08-11 |
| JP2024515405A (ja) | 2024-04-10 |
| US20240066008A1 (en) | 2024-02-29 |
| CA3206892A1 (en) | 2022-07-14 |
| IT202100000119A1 (it) | 2022-07-05 |
| EP4274550A1 (en) | 2023-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3693054A3 (en) | Reducing motility of cancer cells using tumor treating fields (ttfields) | |
| EP1933937B1 (en) | Optimizing characteristics of an electric field to increase the field's effect on proliferating cells | |
| EA200970160A1 (ru) | Устройство и способ неинвазивной обработки кожной ткани | |
| WO2020219517A3 (en) | Electrical stimulation for cancer treatment with internal and external electrodes | |
| EP4292644A3 (en) | Paresthesia-free spinal cord stimulation system | |
| MX2007003095A (es) | Metodos y dispositivos para cerrar los vasos sanguineos inducidos electricamente no termicos. | |
| WO2012088149A4 (en) | High-frequency electroporation for cancer therapy | |
| WO2009038720A3 (en) | Method and apparatus for applying light therapy | |
| NO20050450L (no) | Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft | |
| EP4268743A3 (en) | Implantable arrays for providing tumor treating fields | |
| ITTO20110527A1 (it) | Apparecchio per trattamenti terapeutici con onde elettromagnetiche risonanti pulsate | |
| IL169702A0 (en) | Combination therapy of zd6474 with 5-fu or/and cpt-11 | |
| ATE174785T1 (de) | Behandlung von akne oder von folliculitis barbae | |
| WO2021247794A3 (en) | B7h3-targeting proteins and methods of use thereof | |
| WO2023005720A1 (zh) | 用于选择性破坏或抑制肿瘤细胞有丝分裂的交变电场装置 | |
| WO2020096836A3 (en) | Megahertz compression of nanosecond pulse bursts | |
| WO2016049047A3 (en) | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity | |
| WO2021255676A3 (en) | A method of selectively treating vegetation in a field | |
| CN215275433U (zh) | 治疗用磁环阵列穿戴设备 | |
| MX2023008024A (es) | Dispositivo y farmaco antitumoral para el tratamiento de celulas neoplasicas. | |
| MX2020008881A (es) | Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1. | |
| WO2020033944A3 (en) | Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers | |
| WO2023005719A1 (zh) | 三维磁环治疗装置及其应用 | |
| IL273109B1 (en) | Device for stimulating skin regeneration | |
| US20200324147A1 (en) | A Pain Relief, Fracture Healing and Spinal Fusion Device |